Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.

Naucler, Pontus LU ; Chen, HC. ; Persson, Kenneth LU ; You, SL. ; Hsieh, CY. ; Sun, CA. ; Dillner, Joakim LU and Chen, CJ. (2007) In Journal of General Virology 88(3). p.814-822
Abstract
A nested case–control study of invasive and in situ cervical cancer was performed within a community-based cohort of 13 595 Taiwanese women assembled in 1991, with a follow-up period of 9 years. Baseline serum or plasma samples were analysed for antibodies against human papillomavirus (HPV) types 6, 16 and 18 and Chlamydia trachomatis. In total, 114 cases (42 incident cases identified during follow-up and 72 prevalent cases identified at baseline) and 519 matched controls were included in the study. HPV-16 seropositivity was strongly associated with cervical cancer (OR=6.33; 95 % CI 3.45–11.62). Overall, C. trachomatis was not associated with cervical cancer, but was associated with cervical cancer in analyses restricted to incident cases... (More)
A nested case–control study of invasive and in situ cervical cancer was performed within a community-based cohort of 13 595 Taiwanese women assembled in 1991, with a follow-up period of 9 years. Baseline serum or plasma samples were analysed for antibodies against human papillomavirus (HPV) types 6, 16 and 18 and Chlamydia trachomatis. In total, 114 cases (42 incident cases identified during follow-up and 72 prevalent cases identified at baseline) and 519 matched controls were included in the study. HPV-16 seropositivity was strongly associated with cervical cancer (OR=6.33; 95 % CI 3.45–11.62). Overall, C. trachomatis was not associated with cervical cancer, but was associated with cervical cancer in analyses restricted to incident cases of cancer (OR=2.94; 95 % CI 1.17–7.42) or to cases in which serum samples were analysed (OR=3.13; 95 % CI 1.16–8.47). An antagonistic interaction between HPV-6 and -16 was found in a multiplicative model. These results suggest that different HPV types might interfere in cervical carcinogenesis and that C. trachomatis is associated with cervical cancer in prospective studies, and support the notion that HPV-16 seropositivity is strongly associated with cervical cancer. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of General Virology
volume
88
issue
3
pages
814 - 822
publisher
Microbiology Society
external identifiers
  • scopus:33847644663
  • wos:000245045500010
  • pmid:17325353
ISSN
1465-2099
DOI
10.1099/vir.0.82503-0
language
English
LU publication?
yes
id
78c2ea54-a865-4063-8241-a6760616ee08 (old id 1143688)
date added to LUP
2016-04-01 15:56:10
date last changed
2022-03-22 07:16:36
@article{78c2ea54-a865-4063-8241-a6760616ee08,
  abstract     = {{A nested case–control study of invasive and in situ cervical cancer was performed within a community-based cohort of 13 595 Taiwanese women assembled in 1991, with a follow-up period of 9 years. Baseline serum or plasma samples were analysed for antibodies against human papillomavirus (HPV) types 6, 16 and 18 and Chlamydia trachomatis. In total, 114 cases (42 incident cases identified during follow-up and 72 prevalent cases identified at baseline) and 519 matched controls were included in the study. HPV-16 seropositivity was strongly associated with cervical cancer (OR=6.33; 95 % CI 3.45–11.62). Overall, C. trachomatis was not associated with cervical cancer, but was associated with cervical cancer in analyses restricted to incident cases of cancer (OR=2.94; 95 % CI 1.17–7.42) or to cases in which serum samples were analysed (OR=3.13; 95 % CI 1.16–8.47). An antagonistic interaction between HPV-6 and -16 was found in a multiplicative model. These results suggest that different HPV types might interfere in cervical carcinogenesis and that C. trachomatis is associated with cervical cancer in prospective studies, and support the notion that HPV-16 seropositivity is strongly associated with cervical cancer.}},
  author       = {{Naucler, Pontus and Chen, HC. and Persson, Kenneth and You, SL. and Hsieh, CY. and Sun, CA. and Dillner, Joakim and Chen, CJ.}},
  issn         = {{1465-2099}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{814--822}},
  publisher    = {{Microbiology Society}},
  series       = {{Journal of General Virology}},
  title        = {{Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.}},
  url          = {{http://dx.doi.org/10.1099/vir.0.82503-0}},
  doi          = {{10.1099/vir.0.82503-0}},
  volume       = {{88}},
  year         = {{2007}},
}